EyePoint Pharmaceuticals EYPT
$ 8.4
-6.2%
Quarterly report 2024-Q3
added 11-07-2024
EyePoint Pharmaceuticals Operating Expenses 2011-2024 | EYPT
Annual Operating Expenses EyePoint Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
121 M | 141 M | 92.2 M | 65.9 M | 65.5 M | 29.2 M | 26.1 M | 23.4 M | 20.1 M | 17 M | 14.2 M | 13.9 M | 15 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
141 M | 13.9 M | 49.6 M |
Quarterly Operating Expenses EyePoint Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | - | 29.6 M | 31.9 M | 29.2 M | - | 28.4 M | 30.8 M | 27.6 M | - | 24.4 M | 20 M | 18.3 M | - | 17.7 M | 15.3 M | 18.9 M | - | 16.6 M | 17.4 M | 16.7 M | - | 14 M | 10.5 M | 14 M | 6.74 M | 6.39 M | 13.1 M | 6.39 M | 6.06 M | 7.46 M | 6.06 M | 7.46 M | 5.76 M | 5.45 M | 5.76 M | 5.45 M | 4.64 M | 4.52 M | 4.64 M | 4.52 M | 4.13 M | 4.32 M | 4.13 M | 4.32 M | 3.23 M | 3.14 M | 3.23 M | 3.14 M | 18.3 M | 4.19 M | 18.3 M | 4.19 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
31.9 M | 3.14 M | 12.1 M |